| 股票 | 标签 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 惠泰医疗 688617 | 中性 | 医疗器械 | 38.1 | 34.3 | 1.32 | 11.53 | 0.4% | 50% | 71% | 24% | 0.0 | 2.4% | +29% | -5% | +4% | -11% | -45% | 42% | 356 |
| 英科医疗 300677 | 中性 | 医疗器械 | 31.2 | 16.0 | 0.73 | 1.87 | 0.4% | 10% | 24% | 28% | 5.3 | 2.8% | +14% | +55% | +40% | +41% | -42% | 55% | 355 |
| 乐普医疗 300003 | 中性 | 医疗器械 | 28.1 | 20.2 | 1.19 | 1.32 | 2.8% | 62% | 62% | 14% | 3.5 | 2.7% | -15% | +44% | -25% | -42% | -44% | 43% | 216 |
| 振德医疗 603301 | 中性 | 医疗器械 | 77.4 | — | — | 3.78 | 0.4% | 45% | 35% | 41% | 1.9 | 0.2% | -11% | +234% | +16% | +238% | -35% | 53% | 214 |
| 大博医疗 002901 | 中性 | 医疗器械 | 24.1 | — | — | 4.85 | 1.4% | 58% | 70% | 22% | 0.4 | 4.1% | +22% | +57% | -12% | -29% | -33% | 34% | 171 |
| 南微医学 688029 | 中性 | 医疗器械 | 28.6 | 24.2 | 1.34 | 3.49 | 1.9% | 51% | 64% | 19% | 0.3 | 3.1% | +17% | +24% | -3% | -14% | -33% | 40% | 146 |
| 华兰股份 301093 | 中性 | 医疗器械 | 551.5 | 111.4 | 3.28 | 6.09 | 0.1% | 52% | 42% | 27% | 1.2 | -0.3% | +2% | +182% | +59% | +134% | -48% | 78% | 133 |
| 威高血净 603014 | 中性 | 医疗器械 | 26.6 | 23.9 | 2.17 | 1.81 | 1.7% | 55% | 43% | 38% | 0.0 | 4.3% | +3% | — | -20% | -20% | -35% | 37% | 131 |
| 北芯生命 688712 | 亏损或困境 | 医疗器械 | 105.5 | — | — | 7.15 | — | — | 64% | 4% | 0.4 | 1.3% | +80% | — | — | — | -37% | 51% | 130 |
| 山东药玻 600529 | 中性 | 医疗器械 | 18.4 | 15.9 | 1.45 | 1.48 | 2.4% | 44% | 30% | 35% | 0.0 | 3.3% | +2% | -21% | -3% | -17% | -23% | 20% | 127 |
| 健帆生物 300529 | 现金流红利 | 医疗器械 | 23.7 | 19.3 | 1.93 | 3.72 | 3.2% | 75% | 81% | 36% | 1.5 | 3.4% | -7% | -32% | -19% | -34% | -37% | 27% | 124 |
| 心脉医疗 688016 | 定价权·品牌 | 医疗器械 | 18.8 | 16.9 | 1.21 | 2.52 | 2.6% | 77% | 75% | 17% | 0.0 | 2.7% | +15% | -15% | -4% | -26% | -26% | 32% | 107 |
| 欧普康视 300595 | 定价权·品牌 | 医疗器械 | 21.4 | 19.4 | 1.76 | 1.96 | 1.7% | 35% | 75% | 7% | 0.3 | 5.7% | +7% | -22% | -24% | -42% | -45% | 29% | 99 |
| 佰仁医疗 688198 | 中性 | 医疗器械 | 58.6 | 39.5 | 0.86 | 7.76 | 1.1% | 75% | 89% | 33% | 0.3 | 0.1% | +28% | -1% | -34% | -41% | -46% | 41% | 97 |
| 力诺药包 301188 | 中性 | 医疗器械 | 310.7 | 72.5 | 2.42 | 4.75 | 0.3% | 36% | 21% | 37% | 1.8 | -4.8% | +6% | +18% | +98% | +78% | -56% | 76% | 93 |
| 威高骨科 688161 | 中性 | 医疗器械 | 34.6 | 27.8 | 1.39 | 2.14 | 1.5% | 52% | 66% | 8% | 0.1 | 3.7% | -6% | +12% | -19% | -29% | -44% | 37% | 90 |
| 微电生理 688351 | 纯久期 | 医疗器械 | 148.2 | 131.6 | 3.21 | 4.78 | 0.1% | 19% | 64% | 9% | 0.1 | -0.3% | +21% | +22% | -20% | -29% | -36% | 43% | 87 |
| 爱迪特 301580 | 中性 | 医疗器械 | 37.8 | 28.3 | 0.59 | 3.60 | 0.6% | 27% | 49% | 8% | 0.0 | 1.7% | +20% | +8% | +69% | +49% | -45% | 72% | 79 |
| 爱博医疗 688050 | 中性 | 医疗器械 | 32.0 | 19.0 | 1.00 | 2.64 | 0.8% | 34% | 76% | 30% | 2.2 | 2.8% | +37% | -33% | -35% | -50% | -56% | 31% | 76 |
| 五洲医疗 301234 | 中性 | 医疗器械 | 306.5 | — | — | 9.54 | 0.2% | 51% | 21% | 33% | 0.0 | 0.3% | -6% | +72% | +153% | +148% | -32% | 71% | 73 |
| 中红医疗 300981 | 亏损或困境 | 医疗器械 | 174.7 | — | — | 1.35 | 2.1% | — | 12% | 23% | 4.7 | 0.7% | +15% | +10% | +35% | +4% | -42% | 56% | 71 |
| 昊海生科 688366 | 现金流红利 | 医疗器械 | 45.3 | 20.9 | 1.31 | 1.30 | 3.3% | 111% | 70% | 25% | 1.0 | 1.2% | +5% | -27% | -30% | -47% | -49% | 29% | 69 |
| 赛诺医疗 688108 | 亏损或困境 | 医疗器械 | 82.3 | 81.7 | 2.40 | 6.92 | — | — | 63% | 6% | 0.8 | 2.5% | +40% | +97% | -14% | -51% | -59% | 62% | 69 |
| 正川股份 603976 | 中性 | 医疗器械 | 359.4 | — | — | 5.25 | 0.7% | 99% | 21% | 41% | 2.8 | 1.6% | -6% | +22% | +88% | +64% | -23% | 46% | 61 |
| 蓝帆医疗 002382 | 重资产陷阱 | 医疗器械 | — | 12.4 | 0.83 | 0.84 | — | — | 16% | 32% | 3.2 | 3.1% | +5% | +9% | +6% | -9% | -41% | 37% | 60 |
| 华强科技 688151 | 纯久期 | 医疗器械 | 119.0 | — | — | 1.36 | 0.3% | 47% | 23% | 13% | — | 0.5% | +2% | +33% | -19% | -34% | -44% | 38% | 57 |
| 奥美医疗 002950 | 中性 | 医疗器械 | 22.9 | — | — | 1.51 | 1.6% | 16% | 29% | 33% | 1.4 | -0.3% | -4% | +26% | -18% | -8% | -41% | 48% | 56 |
| 采纳股份 301122 | 中性 | 医疗器械 | 903.8 | 63.9 | 2.56 | 2.93 | 0.1% | 58% | 39% | 33% | 2.4 | -1.2% | -8% | +30% | +74% | +90% | -32% | 60% | 55 |
| 春立医疗 688236 | 轻资产现金牛 | 医疗器械 | 19.6 | 16.6 | 0.75 | 1.79 | 2.5% | 50% | 72% | 13% | 0.0 | 4.4% | -4% | +82% | -37% | -37% | -54% | 44% | 54 |
| 三友医疗 688085 | 纯久期 | 医疗器械 | 92.6 | 47.9 | 0.96 | 2.35 | 0.1% | 10% | 80% | 13% | 0.3 | 1.0% | -6% | +2% | -16% | -33% | -51% | 46% | 50 |
| 三鑫医疗 300453 | 现金流红利 | 医疗器械 | 17.0 | — | — | 3.21 | 3.3% | 59% | 35% | 49% | 0.5 | 4.1% | +7% | +22% | +8% | -8% | -19% | 31% | 48 |
| ST凯利 300326 | 轻资产现金牛 | 医疗器械 | 20.1 | — | — | 1.56 | 1.6% | 46% | 54% | 6% | 0.3 | 4.5% | -6% | -13% | +13% | +10% | -26% | 30% | 45 |
| 济民健康 603222 | 亏损或困境 | 医疗器械 | — | — | — | 3.88 | — | — | 42% | 54% | — | -0.3% | -6% | +34% | -12% | -19% | -50% | 61% | 42 |
| 安杰思 688581 | 定价权·品牌 | 医疗器械 | 19.3 | 17.0 | 1.13 | 1.62 | 2.0% | 38% | 71% | 8% | 0.3 | 3.6% | +17% | +0% | -11% | -38% | -38% | 32% | 41 |
| 国科恒泰 301370 | 纯久期 | 医疗器械 | 152.8 | — | — | 1.66 | 1.4% | 33% | 12% | 9% | 7.8 | 10.7% | +3% | +9% | -25% | -23% | -35% | 28% | 41 |
| 拱东医疗 605369 | 中性 | 医疗器械 | 66.6 | 28.7 | 1.91 | 2.19 | 0.9% | 92% | 33% | 30% | 1.1 | 4.4% | -8% | -6% | -9% | -17% | -32% | 34% | 37 |
| 迈普医学 301033 | 中性 | 医疗器械 | 29.7 | 24.7 | 0.71 | 4.48 | 1.3% | 50% | 82% | 33% | 0.1 | 2.7% | +24% | +64% | -19% | -35% | -45% | 53% | 36 |
| 健尔康 603205 | 中性 | 医疗器械 | 30.8 | — | — | 2.32 | 1.1% | 31% | 24% | 23% | 0.1 | 2.0% | -2% | -2% | -21% | -26% | -37% | 26% | 35 |
| 康德莱 603987 | 中性 | 医疗器械 | 14.5 | — | — | 1.17 | 2.2% | 31% | 33% | 29% | 1.5 | 10.3% | -10% | +23% | -10% | -12% | -28% | 27% | 33 |
| 维力医疗 603309 | 现金流红利 | 医疗器械 | 57.5 | 12.4 | 0.65 | 1.85 | 4.4% | 76% | 44% | 26% | 1.6 | 7.5% | +6% | +19% | -14% | -21% | -29% | 34% | 33 |
| 冠昊生物 300238 | 中性 | 医疗器械 | 178.1 | — | — | 5.25 | — | — | 77% | 42% | 3.0 | -0.2% | +1% | +15% | -17% | -34% | -42% | 44% | 31 |
| 洁特生物 688026 | 中性 | 医疗器械 | 127.6 | 35.6 | 2.09 | 2.67 | 0.3% | 21% | 41% | 34% | 2.6 | 2.4% | -3% | +26% | +29% | +6% | -42% | 53% | 29 |
| 天益医疗 301097 | 亏损或困境 | 医疗器械 | — | — | — | 2.77 | 1.0% | 46% | 38% | 42% | 6.3 | -12.3% | +13% | +44% | -5% | +6% | -36% | 51% | 28 |
| 尚荣医疗 002551 | 亏损或困境 | 医疗器械 | — | — | — | 1.14 | — | 30% | 17% | 13% | — | -0.0% | -6% | +19% | -9% | -28% | -41% | 32% | 28 |
| 南卫股份 603880 | 重资产陷阱 | 医疗器械 | — | — | — | 17.53 | — | — | 9% | 50% | — | 1.1% | +3% | +43% | +55% | +44% | -34% | 49% | 28 |
| 正海生物 300653 | 中性 | 医疗器械 | 38.7 | — | — | 3.08 | 1.8% | 61% | 89% | 21% | — | 2.4% | -6% | -4% | -24% | -32% | -39% | 34% | 27 |
| 西山科技 688576 | 亏损或困境 | 医疗器械 | — | 20.5 | 0.71 | 1.58 | 0.8% | 51% | 70% | 23% | — | -2.8% | +9% | +3% | -6% | -17% | -38% | 38% | 27 |
| 康拓医疗 688314 | 中性 | 医疗器械 | 30.1 | 21.5 | 1.02 | 3.44 | 1.6% | 34% | 81% | 25% | 0.8 | 2.4% | +14% | +16% | -4% | -20% | -48% | 52% | 26 |
| 奥精医疗 688613 | 纯久期 | 医疗器械 | 251.0 | — | — | 1.51 | 0.2% | 30% | 83% | 11% | 1.0 | -1.5% | -3% | +13% | -22% | -24% | -54% | 51% | 22 |
| *ST海利 603718 | 亏损或困境 | 医疗器械 | — | — | — | 2.30 | — | 29% | 59% | 8% | 1.7 | 1.6% | -14% | -11% | -48% | -57% | -64% | 40% | 21 |
| 天臣医疗 688013 | 现金流红利 | 医疗器械 | 39.4 | — | — | 4.03 | 5.2% | 253% | 58% | 32% | 2.2 | -1.6% | +12% | +209% | -48% | -44% | -66% | 46% | 20 |
| 爱伦医疗 920050 | 现金流红利 | 医疗器械 | 18.4 | 17.2 | 0.75 | 1.88 | 3.4% | 54% | 23% | 51% | 2.0 | -5.2% | +20% | — | — | — | — | — | 20 |
| 科莱瑞迪 920072 | 中性 | 医疗器械 | 27.4 | — | — | 2.54 | — | — | 63% | 31% | 0.0 | 2.5% | +11% | — | — | — | — | — | 19 |
| 普昂医疗 920069 | 中性 | 医疗器械 | 17.9 | 15.8 | 0.53 | 2.22 | 1.5% | 24% | 48% | 0% | — | 2.6% | +16% | — | — | — | — | — | 18 |
| 海圣医疗 920166 | 中性 | 医疗器械 | 19.1 | — | — | 2.41 | — | — | 52% | 44% | 0.0 | 0.6% | +9% | — | — | — | — | — | 15 |
| 爱得科技 920180 | 中性 | 医疗器械 | 21.6 | 16.8 | 1.29 | 1.83 | 2.5% | 34% | 59% | 18% | — | 0.1% | +2% | — | — | — | — | — | 14 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。